Company Filing History:
Years Active: 1996-1998
Title: Joseph Edward Curtis: Innovator in Hemophilia Treatment
Introduction
Joseph Edward Curtis is a notable inventor based in Glendora, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of hemophilia. With a total of 2 patents to his name, Curtis has focused on developing innovative solutions for patients with Factor VIII deficiencies.
Latest Patents
Curtis's latest patents include "Activated Human Factor VIII and Method of Preparation" and "Activated Factor VIII as a Therapeutic Agent and Method of Treating." The first patent discloses a method for preparing a purified and stable activated human Factor VIII composition. This composition boasts a specific activity of at least 100,000 units per mg protein, or a potency of at least 15,000 units per ml. The second patent highlights the use of stabilized and activated Factor VIII as a therapeutic agent for treating patients with Factor VIII deficiencies, including those with hemophilia A and patients with Factor VIII inhibitors.
Career Highlights
Curtis has been associated with Baxter International Inc., a leading company in the healthcare sector. His work has focused on advancing treatments that improve the quality of life for individuals suffering from bleeding disorders.
Collaborations
Throughout his career, Curtis has collaborated with esteemed colleagues such as Sam L Helgerson and Roger L Lundblad. These partnerships have contributed to the development of groundbreaking therapies in the field of hemophilia treatment.
Conclusion
Joseph Edward Curtis stands out as an influential inventor whose work has significantly impacted the treatment of hemophilia. His innovative patents and collaborations continue to pave the way for advancements in medical therapies.